Methenamine Hippurate

Drug Levels and Effects:




Summary of Use during Lactation:


Methenaminepasses into milk in small quantities and appears safe to use, even while nursing a newborn.


Drug Levels:


Maternal Levels.

Six mothers nursing newborn infants were givenmethenaminehippurate1 g orally. Five hours after the dose, a meanmethenamineconcentration of 7 mg/L was found in milk. In two other women, milk concentrations averaged 9.1 mg/L 2 to 3 hours after a 1 g dose ofmethenaminehippurateorally and 4.3 mg/L 6 to 7 hours after the dose. Based on the amount of milk ingested, the authors calculated the dose the infants received to be 0.05 to 0.1 mg/kg which is about 1% of the adult dose.[1]

Infant Levels.

Relevant published information was not found as of the revision date.


Effects in Breastfed Infants:


Four newborn infants were allowed to breastfeed in one study after a maternal dose of 1 g ofmethenaminehippurate. No adverse effects were reported.[1]


Possible Effects on Lactation:


Relevant published information was not found as of the revision date.


Alternate Drugs to Consider:


MethenamineMandelate


References:


1. Allgen LG, Holmberg G, Persson B, Sorbo B. Biological fate ofmethenaminein man. Acta Obstet Gynecol Scand. 1979;58:287-93. PMID:484222



Substance Identification:




Substance Name:

MethenamineHippurate

CAS Registry Number:

5714-73-8

Drug Class:


  • Anti-Infective Agents, Urinary


  • Administrative Information:




    LactMed Record Number:


    829


    Last Revision Date:


    Disclaimer:Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.